In many types of solid cancer, interactions between tumour cells and their surrounding microenvironment significantly impact disease progression, and patient prognosis. Tissue engineered models permit investigations of cellular behaviour and interactions in the context of this diseased microenvironment. Previously our group developed the tissue roll for analysis of cellular environment and response (TRACER) platform. To improve the manufacturing robustness of the TRACER platform and to enhance its use for studies involving multiple cell types, we have developed a bioprinting process that deposits cell-laden collagen hydrogel into a thin cellulose scaffolding sheet though a contact-wicking printing process. Printed scaffolds can then be assembled into layered 3D cultures where the location of cells in 3D is dependent on their printed position in the 2D sheet. After a desired culture time 3D TRACERs can be disassembled to easily assess printed cell re-location and phenotype within the heterogeneous microenvironments of the 3D tissue. In our bioprinting manufacturing process, cells are printed into scaffolding sheets, using a modified 3D bioprinter to extrude cells encapsulated in unmodified collagen hydrogel through a polydimethylsiloxane (PDMS) printer extrusion nozzle. This nozzle design reproducibly generated bioink deposition profiles in the scaffold without causing significant cellular damage or compromising scaffold integrity. We assessed print pattern quality and reproducibility and demonstrated printing of co-culture strips containing tumour cells and fibroblasts in separate compartments (i.e. separate TRACER layers). This printing approach will potentially enable adoption of the TRACER platform to the broader community to better understand multi-cell type interactions in 3D tumours and tissues.